Lack of evidence raises questions on long-term PPI use
There is rising concern over the side effects of long-term proton pump inhibitor (PPI) use but limited evidence to warrant discontinuation, a literature review...
Royal Pharmaceutical Society director on the future of pharmacy
Ravi Sharma’s credentials in pharmacy are formidable. Recently appointed the Royal Pharmaceutical Society’s (RPS’s) director for England, he was also National Clinical Lead for...
Moving pharmacy forward
Australia’s healthcare system is strained but there is immense scope for the role of pharmacists to address the sector’s future burdens.
At a time of...
Opinion: When a natural disaster hits
Dispensing from a house, a library and evacuation centres: that’s what happens in a flood.
It’s almost 10 years since a flood put the majority...
Patrick Reid extended interview
I've been lobbying pretty hard for a long time as both a pharmacist and the CEO of a large aged-care provider for pharmacists to...
Diclofenac associated with cardiovascular health risk
A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...

AP











